ibi308
Showing 1 - 8 of 8
Colorectal Cancer Stage IV Trial in Hangzhou (IBI308)
Recruiting
- Colorectal Cancer Stage IV
- IBI308
-
Hangzhou, State..., ChinaXuefeng Fang
Dec 16, 2021
Cancer, Solid Tumor Trial in Beijing (IBI308, IBI308\Cisplatinum\Pemetrexed, IBI308\cisplatin\gemcitabine)
Active, not recruiting
- Cancer, Solid Tumor
- IBI308
- +5 more
-
Beijing, ChinaThe fifth medical center of the PLA general hospital
Feb 18, 2021
NSCLC Trial in Hangzhou, Nanjing (IBI308, Docetaxel)
Active, not recruiting
- Non-small Cell Lung Cancer
- IBI308
- Docetaxel
-
Hangzhou, Zhejiang, China
- +1 more
Jun 1, 2021
Advanced/Metastatic Solid Malignancies Trial in United States (IBI308)
Completed
- Advanced/Metastatic Solid Malignancies
- IBI308
-
Orange, California
- +6 more
May 6, 2021
Esophageal Squamous Cell Carcinoma Trial in Beijing (IBI308, paclitaxel/ irinotecan)
Completed
- Esophageal Squamous Cell Carcinoma
- IBI308
- paclitaxel/ irinotecan
-
Beijing, Beijing, ChinaThe Fifth Medical Center of PLA Ceneral Hospital
Jan 17, 2021
Acral Melanoma That Has Been Removed by Surgery Trial in Beijing (IBI310+IBI308, IBI308, High-dose recombinant interferon a-2B)
Recruiting
- Acral Melanoma That Has Been Removed by Surgery
- IBI310+IBI308
- +2 more
-
Beijing, ChinaBeijing cancer hospital
Jun 22, 2020
Extensive-Stage Small Cell Lung Cancer Trial in Beijing (Paclitaxel/Albumin-Bound Paclitaxel, IBI308)
Unknown status
- Extensive-Stage Small Cell Lung Cancer
- Paclitaxel/Albumin-Bound Paclitaxel
- IBI308
-
Beijing, Beijing, ChinaJunling Li
Aug 13, 2019
Lung Cancer Stage III Trial in Guangzhou (IBI308, Bevacizumab, Pemetrexed)
Recruiting
- Lung Cancer Stage III
- IBI308
- +4 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Apr 14, 2019